Brief: Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
01/07/2026 21:13
BRIEF-Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) July 1 (Reuters) - Autolus Therapeutics PLC 6A3Ay.F:
AUTOLUS THERAPEUTICS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)
Source text: ID:nGNX1HbWfh
Further company coverage: [6A3Ay.F]
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Autolus Therapeutics
See all newsBrief: Autolus Therapeutics Reports Second Quarter 2026 Financial Results And Business Updates
Brief: Autolus Therapeutics Reports Preliminary Second Quarter 2026 Net Product Revenue
Brief: Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Autolus Therapeutics PLC Unit Enters Master Service Agreement With AGC Biologics
Brief: Autolus Therapeutics Appoints Ryan Richardson To Board Of Directors